Middle East and Africa Point-of-Care Diagnostics Market, By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardio metabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumour/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Haematology Testing Products, Other POC Products), Prescription mode (Prescription-Based Testing, OTC Testing), Platform (Lateral Flow Assays /Immunochromatography Tests, Molecular Diagnostics, Immunoassays, Dipsticks, Microfluidics), End User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Pharmacies) – Industry Trends and Forecast to 2031.
Middle East and Africa Point-Of-Care Diagnostics Market Analysis and Size
The Middle East and Africa point-of-care diagnostics market finds extensive applications across various healthcare settings, including remote or underserved areas where access to traditional laboratory facilities is limited. Point-of-care diagnostics play a crucial role in rapid disease detection and management, promoting timely and effective healthcare interventions. These technologies are widely utilized in emergency departments, primary care clinics, and home healthcare settings, enhancing the speed and accuracy of diagnostic processes.
Data Bridge Market Research analyses the Middle East and Africa point-of-care diagnostics market, which was USD 1.54 billion in 2023, is expected to reach USD 2.47 billion by 2031, at a CAGR of 6.1% during the forecast period 2024-2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Point-Of-Care Diagnostics Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardio metabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, Other POC Products), Prescription mode (Prescription-Based Testing, OTC Testing), Type (Devices, Consumables and Kits, Software and Services, Accessories), Platform (Lateral Flow Assays /Immunochromatography Tests, Molecular Diagnostics, Immunoassays, Dipsticks, Microfluidics), End User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Pharmacies)
|
|
Countries Covered
|
Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)
|
|
Market Players Covered
|
BioTech Africa (South Africa), Medtronic (Ireland), BioRad Laboratories, Inc. (U.S.), PTS Diagnostics (U.S.), Trinity Biotech (Ireland), Atlas Medical GmbH (U.K.), Abbott (U.S.), Sysmex Corporation (Japan), BIOMÉRIEUX (France), QuidelOrtho Corporation (U.S.), BD (U.S.), Sekisui Diagnostics (U.S.), F. HoffmannLa Roche Ltd (Switzerland), Beckman Coulter, Inc. (U.S.), ACON Laboratories, Inc. (U.S.), Nova Biomedical (U.S.), Siemens Healthcare GmbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
Point-of-care diagnostics refer to medical tests or examinations conducted at or near the site where patient care is provided. These tests are designed to deliver rapid results, allowing for immediate clinical decisions to be made without the need for sending samples to a centralized laboratory. Point-of-care diagnostics are often portable, user-friendly, and provide quick insights into a patient's health status.
Middle East and Africa Point-Of-Care Diagnostics Market Dynamics
Drivers
- Increasing Prevalence of Infectious Diseases
The increasing prevalence of infectious diseases in the Middle East and Africa serves as a significant driver for the point-of-care diagnostics market in the region. This rise in infectious diseases underscores the pressing need for rapid and efficient diagnostic solutions that can be deployed at the point of care. Point-of-care diagnostics offer quick and accurate results, facilitating timely disease detection and management, which is crucial in regions facing a rising burden of infectious diseases. As a result, the demand for point-of-care diagnostic tools is expected to escalate, driving the growth of the market in the Middle East and Africa.
- Growing Emphasis on Healthcare Infrastructure Development
Governments and healthcare authorities in the Middle East and Africa are investing significantly in improving healthcare infrastructure. Point-of-care diagnostics are essential in resource-limited settings, allowing for quicker and decentralized testing, aligning with the region's focus on enhancing healthcare accessibility and efficiency. This infrastructure development is a key driver propelling the adoption of point-of-care diagnostics in the region.
Opportunities
- Rising Focus on Non-Communicable Diseases (NCDs) Creates Demand
In the Middle East and Africa, the rising focus on non-communicable diseases (NCDs) presents a significant opportunity for the point-of-care diagnostics market. As the region grapples with an increasing prevalence of conditions such as cardiovascular diseases, diabetes, and cancer, there is a growing demand for rapid and accessible diagnostic solutions. Point-of-care diagnostics offer the advantage of quick and convenient testing, aligning with the healthcare priorities in the region and providing a substantial market opportunity for companies catering to the detection and management of NCDs in these areas.
- Rising Adoption of Telehealth in Remote or Rural Areas
The MEA region is witnessing a surge in the adoption of telehealth and remote patient monitoring solutions, particularly in remote or rural areas. Point-of-care diagnostics align well with these trends, offering the capability for patients to conduct certain tests at home while healthcare providers remotely monitor and manage their conditions. This presents an opportunity for the point-of-care diagnostics market to integrate with evolving healthcare delivery models in the region.
Restraints/Challenges
- Regulatory Challenges Hinders Seamless Operations
The Middle East and Africa point-of-care diagnostics market faces regulatory hurdles due to diverse regulatory frameworks across countries in the region. Companies encounter challenges in navigating and complying with varying sets of regulations, impeding the seamless operation and distribution of point-of-care diagnostics. This regulatory complexity adds a layer of restraint, impacting the efficiency and adaptability of companies in the market.
- Economic Constraints Limits Affordability
Economic factors, such as lower disposable income and financial constraints in certain areas of the Middle East and Africa, can impede the affordability of advanced point-of-care diagnostic devices and tests. This may limit the market growth as the adoption of these technologies relies on the purchasing power of both healthcare institutions and individuals.
This Middle East and Africa point-of-care diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa point-of-care diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In November 2022, LumiraDx Healthcare launched a highly sensitive C - reactive protein (CRP) point-of-care (POC) antigen test in India. This test aids in multiple clinical settings, reducing unnecessary antibiotic prescribing and addressing antimicrobial resistance (AMR)
- October 2022 saw the introduction of Genes2Me Pvt. Ltd's Rapi-Q- Point of Care RT PCR solution for human papillomavirus (HPV) and tuberculosis. This CE-IVD-marked POC solution offers fast results in less than 45 minutes, demonstrating superior performance, high sensitivity, and stable detection
- In September 2020, Instrumentation Laboratory gained FDA clearance for its HemosIL Liquid Anti-Xa test kit, marking a significant step in automated homeostasis testing. It is the first direct, oral anti-coagulant test, contributing to market growth
- In August 2020, Siemens Healthcare Private Limited announced the acquisition of Varian, enhancing their capabilities in the fight against cancer and strengthening their position in the healthcare sector. This strategic move aims to boost the company's credibility in the market.
Middle East and Africa Point-Of-Care Diagnostics Market Scope
The Middle East and Africa point-of-care diagnostics market is segmented on the basis of product, prescription mode, type, platform, end user and distribution channel. The growth amongst these segments will help you analyze growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Product
- Glucose Monitoring Products
- Infectious Disease Testing Products
- HIV Testing
- Influenza Testing
- Sexually Transmitted Disease (STD) Testing
- Hepatitis C Testing
- Healthcare-Associated Infection (HAI) Testing
- Tropical Disease Testing
- Respiratory Infection Testing
- Other Infectious Disease Testing
- Cardiometabolic Testing Products
- Pregnancy and Fertility Testing Products
- Coagulation Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Hematology Testing Products
- Other POC Products
Prescription Mode
- Prescription-Based Testing
- OTC Testing
Type
- Devices
- Consumables and Kits
- Software and Services
- Accessories
Platform
- Lateral Flow Assays /Immunochromatography Tests
- Molecular Diagnostics
- Immunoassays
- Dipsticks
- Microfluidics
End User
- Professional Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Outpatient Healthcare
- Ambulatory Care Settings
- Home Care
- Research Laboratories
- Others
Distribution Channel
- Direct Tender
- Retail Pharmacies
Middle East and Africa Point-Of-Care Diagnostics Market Regional Analysis/Insights
The Middle East and Africa point-of-care diagnostics market is segmented on the basis of product, prescription mode, type, platform, end user and distribution channel.
The countries covered in the Middle East and Africa point-of-care diagnostics market report are U Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
South Africa's dominance the point-of-care diagnostics market is attributed to its significant market share held by manufacturers within the country. The presence of key industry players in South Africa, coupled with an escalating diagnostic rate, further solidifies its leadership in the market. The combination of local manufacturing strength and a growing demand for diagnostics underscores South Africa's pivotal role in shaping the landscape of point-of-care diagnostics.
Saudi Arabia dominates the market due to the increasing popularity of wearable or portable glucose monitoring devices. The growing adoption of these devices reflects a broader trend toward personalized and convenient healthcare solutions in the region. This surge in interest is driven by the desire for continuous and easy monitoring of glucose levels, contributing to improved management of diabetes and enhancing overall health outcomes in Saudi Arabia.
The U.A.E. dominates the market due to the rising diagnosis-seeking rate among its population. This trend is further fueled by the growing popularity of wearable and portable glucose monitoring devices. The increased adoption of these advanced technologies reflects a proactive approach toward healthcare management, contributing to the overall improvement in diagnostic practices and patient outcomes in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The Middle East and Africa point-of-care diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for medical Middle East and Africa point-of-care diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Middle East and Africa point-of-care diagnostics market. The data is available for historic period 2016-2021
Competitive Landscape and Middle East and Africa Point-Of-Care Diagnostics Market Share Analysis
Middle East and Africa point-of-care diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Middle East and Africa point-of-care diagnostics market.
Some of the major players operating in the Middle East and Africa point-of-care diagnostics market are:
- BioTech Africa (South Africa)
- Medtronic (Ireland)
- BioRad Laboratories, Inc. (U.S.)
- PTS Diagnostics (U.S.)
- Trinity Biotech (Ireland)
- Atlas Medical GmbH (U.K.)
- Abbott (U.S.)
- Sysmex Corporation (Japan)
- BIOMÉRIEUX (France)
- QuidelOrtho Corporation (U.S.)
- BD (Becton, Dickinson and Company) (U.S.)
- Sekisui Diagnostics (U.S.)
- F. HoffmannLa Roche Ltd (Switzerland)
- Beckman Coulter, Inc. (U.S.)
- ACON Laboratories, Inc. (U.S.)
- Nova Biomedical (U.S.)
- Siemens Healthcare GmbH (Germany)
SKU-